Safe Aktie
| 0,00EUR | 0,00EUR | 0,00% |
WKN DE: A41AHG / ISIN: FR001400ZU25
Personal
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 140 | 134 | 138 | 96 | 100 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,03 | 0,03 | 0,04 | 0,06 | 0,05 |
Bilanz (in Mio. EUR) - Aktiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 8 | 8 | 9 | 8 | 0 |
| Summe Anlagevermögen | 6 | 7 | 7 | 69 | 0 |
| Summe Aktiva | 14 | 15 | 17 | 78 | 0 |
Bilanz (in Mio. EUR) - Passiva
| 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 14 | 14 | 18 | 280 | 0 |
| Summe Eigenkapital | 0 | 0 | -1 | -202 | -8 |
| Summe Passiva | 14 | 15 | 17 | 78 | 0 |
Adresse
| Parc des Bellevues, 95610 Eragny-sur-Oise | |
| Telefon | +33 (1) 34-21-50-00 |
| Fax | +33 (1) 34-21-12-00 |
| Internet | http://www.safeorthopaedics.com |
Management
|
François-Henri Reynaud
Director, Chief Financial & Administrative Officer |
|
Ismaël Nujurally
Independent Director |
|
Nathalie Vazquez
Director-Human Resources |
|
Nikolaus Beyer
Chief Commercial Officer |
|
Philippe Petrou
Independent Director |
|
Pierre Dumouchel
Chairman & Chief Executive Officer |
|
Thomas Droulout
Chief Technology Officer & Director |